Both conventional CD4+CD25hiCD127-/lo and unconventional CD4+CD25-/loCD127- FoxP3+ Tregs exhibited lower intrinsic apoptotic rates in CLL patients versus controls (47). Here, CD4 is linked to B-cell chronic lymphocytic leukemia.